Machine Learning

A new iPSC-derived cell therapy from Unixell Biotech has gained FDA approval for clinical trials, offering a regenerative approach for millions with epilepsy.

With domestic production falling and global supplies at risk, experts warn a helium shortage could cripple key U.S. industries from defense to semiconductors.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

Italian med-tech firm Esaote unveils its AI-driven Prostate Attention Map, promising a new era of accuracy and confidence in prostate cancer detection.

Celebrating its 50th anniversary, Barcelona's mega-show expects 110,000+ visitors, showcasing global food trends, AI, and sustainability.

With a key regulatory approval, fintech firm QuantPower brings institutional-grade automated trading to everyday investors, signaling a shift in India's market.

The nation's largest beauty retailer is betting big on ingestible wellness, partnering with Cymbiotika to bring advanced supplements to over 1,000 stores.

ROHM's new SiC modules are now on DigiKey, democratizing access to next-gen power tech for EVs and industry, challenging market leaders.

With two key executive appointments, BST Global signals a strategic acceleration of its AI-powered project intelligence mission for the AEC industry.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

A European firm is bringing passive brain-computer interface tech to the US, promising safer AI but raising profound questions about mental privacy.

Genspark.ai launches its first 'AI employee,' crossing a $200M run rate and securing a $1.6B valuation in the race to automate knowledge work.

Rivian unveils the R2, a mid-size SUV starting around $45,000. It packs clever features and impressive range, but can the company scale production to meet demand?

A landmark review decodes how ketogenic diets treat epilepsy, highlighting a major research gap and sparking a quest for drugs that mimic the diet's effects.

New AI-powered features are transforming phone calls for people with hearing or speech disabilities, boosting confidence and making conversations feel natural.

A year-long undercover study reveals traditional exam proctoring is failing, putting the value of degrees and professional licenses at risk.

A new partnership combines advanced AI with human expertise to bring hope and clarity to 300 million people on a long, isolating journey to diagnosis.

Heather Peterson joins onPhase as CCO, signaling a strategic push to deliver rapid value to finance teams battling resource scarcity and tech overload.

A new integration with Concrete allows millions of Binance Wallet users to access sophisticated, risk-adjusted USDT yield strategies once reserved for institutions.

Global CRO Emerald Clinical Trials has won a major award for its patient-first strategies in the fast-growing, complex Asia-Pacific clinical trial market.